NextCell Pharma AB

NextCell Pharma AB financial statements

NextCell Pharma AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueSEK 10.94MEODHD
Net income−SEK 35.14MEODHD
Cash and equivalentsSEK 38.72MEODHD

NextCell Pharma AB financials on 6ix · NextCell Pharma AB on 6ix